Attached

July 24, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, Corporate Relationship Department Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (E) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Symbol: LALPATHLAB Scrip Code: 539524 Sub: Press Release on Un-audited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2026 Dear Sir/ Madam, Please find enclosed herewith the Press Release on the Un-audited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2026. We request you to please take the same on record. Thanking You, Yours Faithfully, For Dr. Lal PathLabs Limited Vinay Gujral Company Secretary & Compliance Officer Encl.: As above Classification: Internal For Immediate Release July 24, 2026 Dr Lal PathLabs Limited records revenue of Rs 798 Cr with a growth of 19.1% in Q1 FY27 New Delhi, India, July 24, 2026 – Dr Lal PathLabs Limited (referred to as the “Company”; NSE: LALPATHLAB, BSE: 539524), a leading diagnostic and related healthcare service provider announces their financial results for the quarter ended June 30, 2026. Consolidated Performance Highlights: Q1 FY27 • Revenue increased by 19.1% in Q1 FY27 • EBITDA for Q1 FY27 increased by 28.7% with a margin of 31.0% • PAT for Q1 FY27 is Rs 170 Cr. with a margin for of 21.4% • Interim Dividend of 50% i.e. Rs. 5 per share. • Cash and Cash equivalents as on 30th June 2026 is Rs. 1,693 Cr. • Acquisition of 80% equity stake in Sunshine Healthcare Limited, Ghana engaged in diagnostic business for a consideration not exceeding GHS 45.6 million. • Acquisition of 30% equity stake in Neuome Technologies Private Limited, engaged in innovative solutions in sample preservation and biobanking, for a consideration not exceeding Rs. 3.5 Cr. Financial Overview (Consolidated) in Rs Cr Particulars FY27 FY26 Gr % Revenue 798 670 19.1% Material consumed 152 129 Employee benefit Expenses 133 124 Fees to collection centres 116 96 Other Expenses 150 129 EBITDA 247 192 28.7% Margins 31.0% 28.7% Other Income 32 28 Depreciation Cost 44 35 Finance Cost 6 5 PBT 229 181 26.3% Margins 28.7% 27.0% Income Tax 58 47 PAT 170 134 27.2% Margins 21.4% 20.0% EPS 10.1 7.9 27.8% Dr Lal Pathlabs Limited 12th Floor, Tower-B, SAS Tower, Sector-38, Medicity, Gurgaon 122001, Phone: +91 124 3016500, website: www.lalpathlabs.com 1 About Dr Lal PathLabs Limited Dr Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. Through its’ integrated, nationwide network, the company offer patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. As on March 31, 2026 the company has 312 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab at Kolkata, Bangalore & Mumbai), 7,727 Patient Service Centers (PSCs) and 13,935 Pick-up Points (PUPs). Its’ customers include individual patients, hospitals and other healthcare providers and corporate customers. Contact Details Ved Goel Group Chief Financial Officer & +91 124 3016500 CEO- International Business cfo@lalpathlabs.com Dr Lal PathLabs Limited +91 8604801332 Kritika Khatwani kritika.khatwani@adfactorspr.com Adfactors PR For further information on Dr Lal PathLabs see www.lalpathlabs.com Safe Harbour This release contains statements that contain “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Dr Lal PathLabs future business developments and economic performance. While these forward looking statements indicate our assessment and future expectations concerning the development of our business, a number of risks, uncertainties and other unknown factors could cause actual developments and results to differ materially from our expectations. These factors include, but are not limited to, general market, macro-economic, governmental and regulatory trends, movements in currency exchange and interest rates, competitive pressures, technological developments, changes in the financial conditions of third parties dealing with us, legislative developments, and other key factors that could affect our business and financial performance. Dr Lal PathLabs undertakes no obligation to publicly revise any forward looking statements to reflect future / likely events or circumstances. Dr Lal Pathlabs Limited 12th Floor, Tower-B, SAS Tower, Sector-38, Medicity, Gurgaon 122001, Phone: +91 124 3016500, website: www.lalpathlabs.com 2